ConnSante BioTech, Inc.
Update：2025/12/03
Industries
Main Industry
Health Care
Main Product/Service
1.Cancer Preventive Medicine
2.Cancer Prognosis
3.Cancer drugs R&D
4.Cell therapy & Regenerative medicine
2.Cancer Prognosis
3.Cancer drugs R&D
4.Cell therapy & Regenerative medicine
Founded Year
2019
Unified Business No.
54970398
Status
Closed
Number of Employees
9
Total Paid-in
Capital
29,000,000 (NT$)
Location of Company
Taiwan
, Hsinchu City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
ConnSante Biotech is a molecular and cellular information company.
Based on 25-year research, we develop α-score to check the healthy status of stem cell and immune cells which are critical and essential in the war of cancer.
In the past years, we provided diagnostic service for VIP health check-up, ESG staff healthcare program and cancer patient prognosis in our TAF certificated lab.
We are currently working together with doctors to generate clinical evidence on using α-score as a companion diagnosis in lung cancer with specific treatment modality.
We help users to live with a healthy life style in a scientific way.
We work together with doctors, pharmaceutical and biotech companies enroll patients into clinical trials and get a success.
We are ConnSante.
Based on 25-year research, we develop α-score to check the healthy status of stem cell and immune cells which are critical and essential in the war of cancer.
In the past years, we provided diagnostic service for VIP health check-up, ESG staff healthcare program and cancer patient prognosis in our TAF certificated lab.
We are currently working together with doctors to generate clinical evidence on using α-score as a companion diagnosis in lung cancer with specific treatment modality.
We help users to live with a healthy life style in a scientific way.
We work together with doctors, pharmaceutical and biotech companies enroll patients into clinical trials and get a success.
We are ConnSante.
Corporate Video
